ALQA - Alliqua BioMedical Inc.
Previous close
2.69
2.690 100.000%
Share volume: 8
Last Updated: Fri 03 May 2019 10:00:00 PM CEST
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
11%
Profitability
0%
Dept financing
32%
Liquidity
39%
Performance
10%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 2015 - 2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-23.87%
Return on assets
-9.71%
Return on sales
-187.61%
Return on invested capital
-27.73%
Total debt ratio
36.5%
Debt ratio change over timeo
-1.07%
Current Ratio
2.44%
Quick Ratio
2.3%
Cash Position Ratio
1.87%
Short-term ratios 2018 - 2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.95%
Return on assets
-10.12%
Return on sales
-369.84%
Return on invested capital
31.31%
Total debt ratio
22.7%
Debt ratio change over timeo
-0.73%
Current Ratio
5.76%
Quick Ratio
5.68%
Cash Position Ratio
5.99%
Last quarter ratios 2019
The data are presented for the financials results of the last quarter.
Return on equity
-11.72%
Return on assets
-9.71%
Return on sales
-762.02%
Return on invested capital
-80.71%
Total debt ratio
27.03%
Debt ratio change over time
-0.79%
Current Ratio
8.28%
Quick Ratio
8.17%
Cash Position Ratio
7.93%
Performance ratios (change over 4 years) 2015 - 2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-80.9%
Return on assets
-106.41%
Return on sales
-367.1%
Return on invested capital
-11.01%
Total debt ratio
-106.54%
Debt ratio change over time
-1.07%
Current Ratio
1.71%
Quick Ratio
1.69%
Cash Position Ratio
2.43%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALQA | FTSV | PRNB | RARX |
|---|---|---|---|---|
| Return on equity | -23.87% | -20.12% | -2.86% | -15.36% |
| Return on assets | -9.71% | -17.23% | 1.22% | -13.81% |
| Return on sales | -187.61% | 0% | 0% | 0% |
| Return on invested capital | -27.73% | 182.52% | -1318.09% | 727.04% |
| Profitability | 0% | 6% | 75% | 25% |
| Total debt ratio | 36.5% | 14.82% | 45.27% | 10.14% |
| Debt ratio change over time | -1.07% | -0.91% | -1.05% | -1% |
| Dept financing | 20% | 33% | 25% | 6% |
| Current Ratio | 5.76% | 8.44% | 8.12% | 15.71% |
| Quick Ratio | 5.68% | 0% | 0% | 0% |
| Cash Position Ratio | 5.99% | 1.09% | 2.09% | 19.7% |
| Liquididy | 33% | 16% | 18% | 50% |
| Short-term ratios | ALQA | FTSV | PRNB | RARX |
|---|---|---|---|---|
| Return on equity | -11.95% | -19.8% | -2.86% | -13.72% |
| Return on assets | -10.12% | -17.17% | 1.22% | -12.83% |
| Return on sales | -369.84% | 0% | 0% | 0% |
| Return on invested capital | 31.31% | 197.59% | -1318.09% | 3072.87% |
| Profitability | 0% | 2% | 75% | 25% |
| Total debt ratio | 22.7% | 13.65% | 45.27% | 8.38% |
| Debt ratio change over time | -0.73% | -0.91% | -1.05% | -0.99% |
| Dept financing | 38% | 8% | 25% | 5% |
| Current Ratio | 5.76% | 8.44% | 8.12% | 15.71% |
| Quick Ratio | 5.68% | 0% | 0% | 0% |
| Cash Position Ratio | 5.99% | 1.09% | 2.09% | 19.7% |
| Liquididy | 42% | 15% | 16% | 50% |